In a mouse model of orthotopic pancreatic cancer, anchoring of fibronectin extra domain B targeting peptide to abundant tumor-associated fibronectin in ECM promoted the retention of these nanosystems in the tumor stroma after intravenous injection. The gene discussed is FN1; the disease is familial pancreatic carcinoma.